Technical Analysis for CFRX - ContraFect Corporation

Grade Last Price % Change Price Change
grade A 8.8 -0.11% -0.01
CFRX closed down 0.11 percent on Friday, February 28, 2020, on 70 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average.
Earnings due: Mar 12
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical CFRX trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
New Downtrend Bearish 0.00%
50 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Fell Below 20 DMA Bearish -0.11%
1,2,3 Pullback Bullish Bullish Swing Setup -0.11%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

ContraFect Corporation operates as a biotechnology company that focuses on development and commercialization of protein and antibody products for life-threatening, drug-resistant infectious diseases, and particularly those used in hospital-based settings. The company's product candidates are CF-301 and CF-302, the bacteriophage lysins for the treatment of staph aureus infections; and CF-404, a cocktail of monoclonal antibodies for the treatment of life-threatening seasonal and pandemic varieties of influenza. The company was founded in 2008 and is headquartered in Yonkers, New York.
Biotechnology Medical Specialties Infectious Diseases Antibodies Monoclonal Antibodies Influenza Microbiology Healthcare Associated Infections Staphylococcus Aureus

Is CFRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.4
52 Week Low 2.693
Average Volume 290,553
200-Day Moving Average 5.11
50-Day Moving Average 8.53
20-Day Moving Average 8.98
10-Day Moving Average 10.31
Average True Range 1.24
ADX 36.68
+DI 23.37
-DI 24.98
Chandelier Exit (Long, 3 ATRs ) 8.39
Chandelier Exit (Short, 3 ATRs ) 9.61
Upper Bollinger Band 12.03
Lower Bollinger Band 5.93
Percent B (%b) 0.47
BandWidth 68.00
MACD Line 0.39
MACD Signal Line 0.48
MACD Histogram -0.0847
Fundamentals Value
Market Cap 648.15 Million
Num Shares 73.7 Million
EPS -0.47
Price-to-Earnings (P/E) Ratio -18.72
Price-to-Sales 0.00
Price-to-Book 3.76
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.78
Resistance 3 (R3) 9.70 9.30 9.61
Resistance 2 (R2) 9.30 9.05 9.34 9.56
Resistance 1 (R1) 9.05 8.90 9.18 9.13 9.50
Pivot Point 8.65 8.65 8.71 8.69 8.65
Support 1 (S1) 8.40 8.40 8.53 8.48 8.10
Support 2 (S2) 8.00 8.25 8.04 8.04
Support 3 (S3) 7.75 8.00 7.99
Support 4 (S4) 7.83